Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-079393
Filing Date
2026-07-20
Accepted
2026-07-20 07:00:22
Documents
2
Period of Report
2026-07-20

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0298498-6k_kamada.htm 6-K 16306
2 KAMADA ANNOUNCES A THREE-YEAR $50 MILLION SALES AGREEMENT TO SUPPLY PLASMA TO A ea029849801ex99-1.htm EX-99.1 12437
  Complete submission text file 0001213900-26-079393.txt   29762
Mailing Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402
Business Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402 97289406472
KAMADA LTD (Filer) CIK: 0001567529 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35948 | Film No.: 261185141
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)